8-K
filed May 11, 2026, 7:59 PM ET
ticker COCH
CIK 0001840877
earnings
confidence high
sentiment positive
materiality 0.85
Envoy Medical completes pivotal trial enrollment for fully implanted cochlear implant; raises $30M
Envoy Medical, Inc.
2026-Q1 EPS reported
-$0.08
revenue$39,000
- Completed enrollment of 56 patients in U.S. pivotal trial for Acclaim cochlear implant; first three patients reach 12-month endpoint.
- Closed upsized public offering for $30M gross proceeds (up to $78M with warrants); led by Nantahala Capital and Broadfin Holdings.
- Interim data from first 10 patients: CNC word recognition improved from 15.2% to 39.2%; no serious adverse events; 24-hour wear time.
- Q1 2026 revenue $39k; R&D expense $3.6M; cash $25.3M as of March 31, 2026.
- Appointed medical device veteran Chas McKhann to Board; expanded IP portfolio to 47 patents.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-26-054185
- form_type
- 8-K
- ticker
- COCH
- cik
- 0001840877
- company_name
- Envoy Medical, Inc.
- filed_at
- 2026-05-11T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:33.094661+00:00
- generated_at
- 2026-05-14T18:58:19.782859+00:00
- sec_items
- ["2.02", "9.01"]
- event_type
- earnings
- sentiment
- positive
- materiality_score
- 0.85
- calibrated_materiality_score
- 0.85
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-26-054185
- json_url
- https://secwatch.observer/filing/0001213900-26-054185.json
- markdown_url
- https://secwatch.observer/filing/0001213900-26-054185.md
- text_url
- https://secwatch.observer/filing/0001213900-26-054185.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1840877/000121390026054185/0001213900-26-054185-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1840877/000121390026054185/ea0289965-8k_envoy.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
GMRS
GMR Solutions Q1 revenue $1.46B (+6.6% YoY), net income $106M (+180% YoY), guides FY26 rev $5.9-6.2B
GMR Solutions Inc.
June 1, 2026, 4:45 PM ET
earnings
Items 2.02, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
Net Revenue was $39 for the three months ended March 31, 2026.
Comparable filing
today announced financial results for the first quarter ended March 31, 2026, and full year 2026 financial guidance. First Quarter 2026 Financial Highlights ● Net revenue of $1,457.6 million, up 6.6% compared to $1,367.4 million in the first quarter of 2025 ● Net income of $106.3 million, up 179.7% compared to $38.0 million in the first quarter of 2025 ● Adjusted
Filing page
SEC filing
HPE
HPE Q2 FY26: record revenue $10.7B (+40%), raises FY26 guidance, introduces FY27 framework
Hewlett Packard Enterprise Co
June 1, 2026, 4:09 PM ET
earnings
Items 1.01, 2.02, 5.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
Net Revenue was $39 for the three months ended March 31, 2026.
Comparable filing
gross margin, and non-GAAP diluted net EPS, as well as its highest-ever free cash flow generation for a second quarter. Second Quarter Fiscal 2026 Financial Results • Revenue : $10.7 billion, up 40% from the prior-year period • Gross margins : ◦ GAAP of 36.5%, up 810 basis points from the prior-year period and up 60 basis points sequentially ◦ Non-GAAP (1) of 36.9%,
Filing page
SEC filing
CRDO
Credo Q4 revenue $437M (+157% YoY); guides Q1 $465-475M; CEO awarded 1.44M performance-based RSUs
Credo Technology Group Holding Ltd
June 1, 2026, 4:08 PM ET
earnings
Items 2.02, 5.02, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
Net Revenue was $39 for the three months ended March 31, 2026.
Comparable filing
On June 1, 2026, Credo Technology Group Holding Ltd (the "Company") issued a press release announcing its financial results for the fiscal year ended May 2, 2026.
Filing page
SEC filing
URG
Ur-Energy Q1 2026: pounds captured up 41% QoQ, avg price $70.98, Shirley Basin commenced
UR-ENERGY INC
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
Net Revenue was $39 for the three months ended March 31, 2026.
Comparable filing
a 14% increase over Q4 2025 and a 13% increase over Q1 2025. Financial Performance ◾ Contracted Sales: We sold 55,000 produced pounds of U 3 O 8 as anticipated, generating $3.9 million in revenue, with a majority of our 2026 deliveries scheduled for the latter part of the year to complement the ramp-up and start-up schedules of Lost Creek and Shirley Basin. ◾
Filing page
SEC filing
ACH
Accendra Health Q1 revenue $627.8M, adj. EBITDA $58.4M; >$1.5B debt optimization
ACCENDRA HEALTH INC/VA/
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
Net Revenue was $39 for the three months ended March 31, 2026.
Comparable filing
Commission this morning. Details on First Quarter 2026 Results First Quarter Results (1) ($ in millions, except per share data) 1Q26 1Q25 Net Revenue $ 627.8 $ 673.9 Loss from continuing operations, net of tax, GAAP $ (6.5) $ (3.8) Adj. net (loss) income from continuing operations, Non-GAAP $ (3.1) $ 23.2
Filing page
SEC filing
LQDA
Liquidia Q1 2026 net income $53M vs $38M loss YoY; YUTREPIA sales $130M
Liquidia Corp
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 8.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
Net Revenue was $39 for the three months ended March 31, 2026.
Comparable filing
First Quarter 2026 Financial Results YUTREPIA sales led to the company’s third consecutive quarter of profitability with net income of $52.9 million and positive non-GAAP adjusted EBITDA of $71.2 million in the first quarter of 2026. Cash and cash equivalents totaled $222.8 million as of March 31, 2026, compared to $190.7 million as of December 31, 2025. Product sales, net, were $129.9 million for the three months ended March 31, 2026.
Filing page
SEC filing
TH
Target Hospitality Q1 revenue up 4% but net loss widens to $13M; announces $750M AI infrastructure contract
Target Hospitality Corp.
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
Net Revenue was $39 for the three months ended March 31, 2026.
Comparable filing
today reported results for the three months ended March 31, 2026. Financial Highlights for the quarter ended March 31, 2026 ● Revenue of $72.8 million. ● Net loss of ($13.0) million. ● Basic and diluted loss per share of $0.13 . ● Adjusted EBITDA (1) of $9.9 million. ● Net Cash Provided by Operating Activities of $7.0 million and Discretionary Cash
Filing page
SEC filing
FSK
FSK posts Q1 GAAP loss of $1.57/sh, NAV falls to $18.83; announces $150M preferred, tender, buyback
FS KKR Capital Corp
May 11, 2026, 7:59 PM ET
earnings
Items 1.01, 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
Net Revenue was $39 for the three months ended March 31, 2026.
Comparable filing
Earnings (Loss) per share of ($1.57), compared to Earnings (Loss) per share of ($0.41) for the quarter ended December 31, 2025
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.